Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInvestment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Abivax (ABVX) Gross Profit: 2022-2025

Historic Gross Profit for Abivax (ABVX) over the last 1 years, with Jun 2025 value amounting to $59.3 million.

  • Abivax's Gross Profit rose 28.42% to $59.3 million in Q2 2025 from the same period last year, while for Jun 2025 it was $99.7 million, marking a year-over-year increase of 141.91%. This contributed to the annual value of $13.3 million for FY2024, which is 167.56% up from last year.
  • Abivax's Gross Profit amounted to $59.3 million in Q2 2025, which was up 1,307.56% from -$4.9 million recorded in Q1 2025.
  • In the past 5 years, Abivax's Gross Profit registered a high of $59.3 million during Q2 2025, and its lowest value of -$4.9 million during Q1 2024.
  • In the last 3 years, Abivax's Gross Profit had a median value of -$453,720 in 2023 and averaged $15.8 million.
  • Per our database at Business Quant, Abivax's Gross Profit plummeted by 687,768.93% in 2023 and then rose by 28.42% in 2025.
  • Abivax's Gross Profit (Quarterly) stood at $4.69 in 2022, then slumped by 687,768.93% to -$32,273 in 2023, then plummeted by 2,611.74% to -$875,166 in 2024, then increased by 28.42% to $59.3 million in 2025.
  • Its last three reported values are $59.3 million in Q2 2025, -$4.9 million for Q1 2025, and -$875,166 during Q4 2024.